Skip to content
Parker Institute for Cancer Immunotherapy
Search
Search Close

Strategic Partnerships

Strategic Partnerships

More collaboration means more breakthroughs - from idea to impact

We have an ambitious agenda. Collaborations beyond academia are critical for us to elevate our research projects and clinical trials, and to make our bold ideas a reality. Partnerships with the right pharmaceutical companies, biotechs and nonprofits propel cutting-edge cancer research. Investments in new technologies and emerging companies speed discoveries. This new level of collaboration can change the lives of patients—and ultimately, the world.

See Our Partners

40+

Industry & Nonprofit Collaborations

6

STRATEGIC INvestments

Meet Our Experts

Scientific Partnerships

Melinda Griffith, JD
Chief Legal Counsel and Vice President, Strategic Alliances Management

John Connolly, PhD
Chief Scientific Officer

Nonprofit Partnerships

Jennifer Haslip
Vice President, Communications

The PICI Advantage

PICI offers a unique combination of expertise, resources and capabilities that includes:

  • Bridging the gap between academia and industry
  • Co-funding novel ideas and research
  • Sharing valuable data and insights from our research
  • Providing access to coordinated, cutting-edge lab infrastructure
  • Developing clinical study designs and supporting patient accrual
  • Offering the option to license future PICI discoveries and IP

Partners Help Fuel Discoveries

We look to our partners to elevate every research project and clinical trial by:

  • Co-funding novel ideas and research
  • Sharing samples and data
  • Providing experimental drugs and targets
  • Offering cutting-edge tools, reagents and sequencing